Nova Eye Medical Limited (ASX:EYE)

31.0¢

right-arrow Created with Sketch. -0.01 (-3.13%)
MCAP $46.57M
Last trade 15.57pm 01/12/2021 20mins delayed

Latest Announcements

30/11/2021EYENova Eye Medical Limited
30/11/2021EYENova Eye Medical Limited
30/11/2021EYENova Eye Medical Limited
30/11/2021EYENova Eye Medical Limited
24/11/2021EYENova Eye Medical Limited
24/11/2021EYENova Eye Medical Limited
24/11/2021 Price SensitivePSEYENova Eye Medical Limited
24/11/2021EYENova Eye Medical Limited

Company Overview

Nova Eye Medical Limited is an Australia-based medical technology company. The Company is focused on developing, manufacturing and selling a portfolio of ophthalmic treatment technologies and devices. Its technologies include iTrack minimally invasive glaucoma surgery (MIGS), which is a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patients' reliance on anti-glaucoma medications for mild-moderate glaucoma. Its Molteno3 glaucoma drainage device platform is designed to manage surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma. The Company's 2RT is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD).

EYE in the news

Nova Eye Medical (EYE) acquires patents relating to glaucoma treatments as the…

Search Previous Announcements